Aboshaiqah Ahmad, Aboshaiqah Bader, Alharbi Naif M, Almunyif Tariq I, Binghanim Saad D, Almejalli Abdullah K
College of Nursing, King Saud University, Riyadh, SAU.
Department of Medicine, King Saud Bin Abdulaziz University for Health Sciences College of Medicine, Riyadh, SAU.
Cureus. 2024 Nov 27;16(11):e74559. doi: 10.7759/cureus.74559. eCollection 2024 Nov.
Vitamin B12 deficiency is a recognized concern among patients with type 2 diabetes mellitus (T2DM) using metformin due to its potential impact on health outcomes. This study investigates the prevalence of vitamin B12 deficiency among diabetic patients using metformin at Dr. Sulaiman Al Habib Medical Group (HMG) hospitals.
This retrospective cohort study utilized electronic medical records from the VIDA system (www.cloudsolutions.com) over a one-year period. Participants included adult T2DM patients managed with metformin therapy. Data collection involved demographic details, medical history, medication usage, and serum vitamin B12 levels. Statistical analyses included descriptive statistics and comparative tests to assess deficiency prevalence across demographics.
Among the study population (N=37,781), vitamin B12 deficiency prevalence ranged from 460 (4.6%) to 507 (5.5%) across four quarters of 2023. Females exhibited a higher prevalence than males (P < 0.05), particularly in the second and fourth quarters. Age-related analyses identified younger and middle-aged groups (≤25 years and 36-45 years) as having higher deficiency rates (P < 0.001). Medication use, specifically metformin, correlated with increased deficiency prevalence (P < 0.001).
The findings underscore the significance of gender, age, and medication use in influencing vitamin B12 status among diabetic patients using metformin. The study highlights the need for tailored monitoring strategies and interventions to mitigate deficiency risks and optimize patient outcomes. Future research should explore mechanisms underlying these associations and expand findings to broader populations.
This study provides critical insights into the epidemiology of vitamin B12 deficiency among diabetic patients using metformin at HMG hospitals. The results emphasize the importance of personalized healthcare approaches to address nutrient deficiencies and improve overall patient care. This study summarizes the key elements of your research paper, focusing on the prevalence of vitamin B12 deficiency in relation to metformin use among diabetic patients.
维生素B12缺乏是使用二甲双胍的2型糖尿病(T2DM)患者中一个公认的问题,因为它可能对健康结果产生影响。本研究调查了苏莱曼·哈比卜博士医疗集团(HMG)医院中使用二甲双胍的糖尿病患者维生素B12缺乏的患病率。
这项回顾性队列研究利用了VIDA系统(www.cloudsolutions.com)一年期间的电子病历。参与者包括接受二甲双胍治疗的成年T2DM患者。数据收集涉及人口统计学细节、病史、用药情况和血清维生素B12水平。统计分析包括描述性统计和比较测试,以评估不同人口统计学特征的缺乏患病率。
在研究人群(N = 37781)中,2023年四个季度的维生素B12缺乏患病率在460(4.6%)至507(5.5%)之间。女性的患病率高于男性(P < 0.05),特别是在第二和第四季度。年龄相关分析确定年轻和中年组(≤25岁和36 - 45岁)的缺乏率较高(P < 0.001)。用药情况,特别是二甲双胍,与缺乏患病率增加相关(P < 0.001)。
研究结果强调了性别、年龄和用药情况对使用二甲双胍的糖尿病患者维生素B12状态的影响。该研究强调需要制定针对性的监测策略和干预措施,以降低缺乏风险并优化患者结局。未来的研究应探索这些关联背后的机制,并将研究结果扩展到更广泛的人群。
本研究为HMG医院中使用二甲双胍的糖尿病患者维生素B12缺乏的流行病学提供了关键见解。结果强调了个性化医疗方法对于解决营养缺乏和改善整体患者护理的重要性。本研究总结了你研究论文的关键要素,重点关注与糖尿病患者使用二甲双胍相关的维生素B12缺乏患病率。